87 related articles for article (PubMed ID: 12408666)
1. Activity of azithromycin against Leishmania major in vitro and in vivo.
Krolewiecki A; Leon S; Scott P; Abraham D
Am J Trop Med Hyg; 2002 Sep; 67(3):273-7. PubMed ID: 12408666
[TBL] [Abstract][Full Text] [Related]
2. Determination of intracellular efficacies of azithromycin against Leishmania major infection in human neutrophils in vitro.
Tanyuksel M; Bas AL; Araz E; Aybay C
Cell Biochem Funct; 2003 Mar; 21(1):93-6. PubMed ID: 12579528
[TBL] [Abstract][Full Text] [Related]
3. Antileishmanial activity of azithromycin against Leishmania (Leishmania) amazonensis, Leishmania (Viannia) braziliensis, and Leishmania (Leishmania) chagasi.
de Oliveira-Silva F; de Morais-Teixeira E; Rabello A
Am J Trop Med Hyg; 2008 May; 78(5):745-9. PubMed ID: 18458308
[TBL] [Abstract][Full Text] [Related]
4. S-nitrosoglutathione (GSNO) is cytotoxic to intracellular amastigotes and promotes healing of topically treated Leishmania major or Leishmania braziliensis skin lesions.
Costa IS; de Souza GF; de Oliveira MG; Abrahamsohn Ide A
J Antimicrob Chemother; 2013 Nov; 68(11):2561-8. PubMed ID: 23788476
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of intracellular proliferation of Leishmania parasites in vitro and suppression of skin lesion development in BALB/c mice by a novel lipid A analog (ONO-4007).
Khan MA; Maruno M; Khaskhely NM; Ramzi ST; Hosokawa A; Uezato H; Landires EA; Hashiguchi Y; Nonaka S
Am J Trop Med Hyg; 2002 Aug; 67(2):184-90. PubMed ID: 12389945
[TBL] [Abstract][Full Text] [Related]
6. Anti Leishmania activity of Lucilia sericata and Calliphora vicina maggots in laboratory models.
Sanei-Dehkordi A; Khamesipour A; Akbarzadeh K; Akhavan AA; Mir Amin Mohammadi A; Mohammadi Y; Rassi Y; Oshaghi MA; Alebrahim Z; Eskandari SE; Rafinejad J
Exp Parasitol; 2016 Nov; 170():59-65. PubMed ID: 27567983
[TBL] [Abstract][Full Text] [Related]
7. Leishmanicidal activity of the Agaricus blazei Murill in different Leishmania species.
Valadares DG; Duarte MC; Oliveira JS; Chávez-Fumagalli MA; Martins VT; Costa LE; Leite JP; Santoro MM; Régis WC; Tavares CA; Coelho EA
Parasitol Int; 2011 Dec; 60(4):357-63. PubMed ID: 21723957
[TBL] [Abstract][Full Text] [Related]
8. Effect of BMAP-28 antimicrobial peptides on Leishmania major promastigote and amastigote growth: role of leishmanolysin in parasite survival.
Lynn MA; Kindrachuk J; Marr AK; Jenssen H; Panté N; Elliott MR; Napper S; Hancock RE; McMaster WR
PLoS Negl Trop Dis; 2011; 5(5):e1141. PubMed ID: 21655347
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of total phenolic fraction derived from extra virgin olive oil for its antileishmanial activity.
Koutsoni OS; Karampetsou K; Kyriazis ID; Stathopoulos P; Aligiannis N; Halabalaki M; Skaltsounis LA; Dotsika E
Phytomedicine; 2018 Aug; 47():143-150. PubMed ID: 30166099
[TBL] [Abstract][Full Text] [Related]
10. In vitro antileishmanial activity of novel azoles (3-imidazolylflavanones) against promastigote and amastigote stages of Leishmania major.
Shokri A; Emami S; Fakhar M; Teshnizi SH; Keighobadi M
Acta Trop; 2017 Mar; 167():73-78. PubMed ID: 28017860
[TBL] [Abstract][Full Text] [Related]
11. An effective in vitro and in vivo antileishmanial activity and mechanism of action of 8-hydroxyquinoline against Leishmania species causing visceral and tegumentary leishmaniasis.
Costa Duarte M; dos Reis Lage LM; Lage DP; Mesquita JT; Salles BC; Lavorato SN; Menezes-Souza D; Roatt BM; Alves RJ; Tavares CA; Tempone AG; Coelho EA
Vet Parasitol; 2016 Feb; 217():81-8. PubMed ID: 26827866
[TBL] [Abstract][Full Text] [Related]
12. In vitro evaluation of the anti-leishmanial activity and toxicity of PK11195.
Guedes CES; Dias BRS; Petersen ALOA; Cruz KP; Almeida NJ; Andrade DR; Menezes JPB; Borges VM; Veras PST
Mem Inst Oswaldo Cruz; 2018 Feb; 113(4):e170345. PubMed ID: 29412342
[TBL] [Abstract][Full Text] [Related]
13. Leishmania promastigotes evade interleukin 12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells during initiation of infection.
Reiner SL; Zheng S; Wang ZE; Stowring L; Locksley RM
J Exp Med; 1994 Feb; 179(2):447-56. PubMed ID: 7905017
[TBL] [Abstract][Full Text] [Related]
14. Repurposing azole antifungals into antileishmanials: Novel 3-triazolylflavanones with promising in vitro antileishmanial activity against Leishmania major.
Keighobadi M; Emami S; Fakhar M; Shokri A; Mirzaei H; Hosseini Teshnizi S
Parasitol Int; 2019 Apr; 69():103-109. PubMed ID: 30582997
[TBL] [Abstract][Full Text] [Related]
15. The inhibition of arginase by N(omega)-hydroxy-l-arginine controls the growth of Leishmania inside macrophages.
Iniesta V; Gómez-Nieto LC; Corraliza I
J Exp Med; 2001 Mar; 193(6):777-84. PubMed ID: 11257143
[TBL] [Abstract][Full Text] [Related]
16. In vivo antileishmanial action of Ir-(COD)-pentamidine tetraphenylborate on Leishmania donovani and Leishmania major mouse models.
Loiseau PM; Mbongo N; Bories C; Boulard Y; Craciunescu DG
Parasite; 2000 Jun; 7(2):103-8. PubMed ID: 10887656
[TBL] [Abstract][Full Text] [Related]
17. Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium.
Bermudez LE; Inderlied CB; Kolonoski P; Petrofsky M; Aralar P; Wu M; Young LS
Antimicrob Agents Chemother; 2001 Jan; 45(1):217-22. PubMed ID: 11120969
[TBL] [Abstract][Full Text] [Related]
18. Leishmania major-infected murine langerhans cell-like dendritic cells from susceptible mice release IL-12 after infection and vaccinate against experimental cutaneous Leishmaniasis.
von Stebut E; Belkaid Y; Nguyen BV; Cushing M; Sacks DL; Udey MC
Eur J Immunol; 2000 Dec; 30(12):3498-506. PubMed ID: 11093169
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological evaluation of anti-leishmanial activity by in vivo nitric oxide modulation in Balb/c mice infected with Leishmania major MRHO/IR/75/ER: an Iranian strain of cutaneous leishmaniasis.
Nahrevanian H; Farahmand M; Aghighi Z; Assmar M; Amirkhani A
Exp Parasitol; 2007 Jul; 116(3):233-40. PubMed ID: 17335813
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo prophylactic and curative activity of the triterpene saponin PX-6518 against cutaneous Leishmania species.
Inocêncio da Luz RA; Vermeersch M; Deschacht M; Hendrickx S; Van Assche T; Cos P; Maes L
J Antimicrob Chemother; 2011 Feb; 66(2):350-3. PubMed ID: 21131319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
